| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3876698 | The Journal of Urology | 2006 | 7 Pages |
Abstract
This study demonstrates that many patients have slow progression despite increasing PSA following RRP and adjuvant hormonal therapy. Nodal status, cancer grade and PSADT are predictive of sRFS and CSS, and may be a useful means of selecting patients for future adjuvant therapy trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Shomik Sengupta, Michael L. Blute, Stephanie M. Bagniewski, Robert P. Myers, Eric J. Bergstralh, Bradley C. Leibovich, Horst Zincke,